This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Advancing Radiotheranostics: A Multidisciplinary Approach to Clinical Development

1:30 pm - Wednesday 22nd July 2026

Understand the clinical opportunities and challenges shaping the rapidly evolving radiotheranostic landscape.

Explore best practices in clinical operations for executing complex radiotheranostic studies across trial sites.

Learn how robust clinical supply logistics and risk management strategies enable reliable delivery and scalability throughout clinical development.

Kennedy Diorio

Senior Clinical Logistics Monitor

PPD - Thermo Fisher Scientific Inc.

Justin Martin

Senior Director - Project Oversight , Hematology & Oncology

PPD - Thermo Fisher Scientific Inc.

Binh Nguyen

Vice President - Global Product Development

PPD - Thermo Fisher Scientific Inc.